-
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
28 Mar 2024 04:56 GMT
… for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies … to the armamentarium of available therapies and Heart failure,” Muthu said.
-
Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session
28 Mar 2024 16:00 GMT
… to the bedside: Advances in heart failure & cardiomyopathies
Poster Presentation: … .gov.
About Edgewise Therapeutics
Edgewise Therapeutics is a leading muscle … biopharmaceutical company developing novel therapeutics for muscular dystrophies and …
-
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
28 Mar 2024 12:30 GMT
… of Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction … Research Foundation’s Technology and Heart Failure Therapeutics (THT) 2024 Conference in … with acutely decompensated heart failure. Results of Tenax Therapeutics’ Phase 2 HELP …
-
Bayer working on Phase 3 trials for Finerenone as potential treatment for heart failure, non-diabetes CKD
27 Mar 2024 13:21 GMT
… or related conditions?
Innovative therapies and timely treatment can … as a potential treatment for heart failure and non-diabetes CKD. … and availability of innovative therapies, so they can help … kidney failure. Newer advanced therapies can also reduce the …
-
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure
26 Mar 2024 11:21 GMT
… 2 Pulmonary Hypertension secondary to Heart Failure with preserved Ejection Fraction ( … broad range of potential therapeutic applications with significant benefits … its treatment.
About Tectonic Therapeutic
Tectonic Therapeutic, co-founded by Andrew …
-
Novel CAR-T Cell Therapy Trial for Lupus Launched by Atlantic Health System
27 Mar 2024 21:14 GMT
… targeting lupus. Having strong cellular therapy and rheumatology research programs has … . The collaboration between our cellular therapy and rheumatology programs was crucial … reverse the effects of congestive heart failure. Whenever there is an opportunity …
-
US FDA Approves Merck's Therapy for Rare Lung Condition
27 Mar 2024 12:43 GMT
… 4% in extended trading. The therapy, branded Winrevair, is approved for … to pump blood, eventually causing heart failure. "We see sotatercept having … a note. Schott estimates the therapy to reach peak sales of …
-
Novo to acquire heart failure drug in $1B deal for Cardior
25 Mar 2024 16:46 GMT
… and its experimental treatment for heart failure, the companies announced Monday.
Cardior … study involving 280 people with heart failure who previously experienced a heart … Pharma, Embark Biotech and EraCal Therapeutics.
With Cardior, meanwhile, Novo adds …
-
Sequana’s DSR therapy shows promise in heart failure patients
25 Mar 2024 15:22 GMT
… sodium removal (DRS) therapy in patients with congestive heart failure.
The results showed … diuretic-resistant heart failure improved and treatment with DRS therapy can also … evaluate the DRS therapy in patients with congestive heart failure who are resistant …
-
Thryv Therapeutics to Present Results of Wave I Part 1 Clinical Study at American College of Cardiology Conference in Atlanta, Georgia on April 7th, 2024
26 Mar 2024 18:58 GMT
… cardiac death.
About Thryv Therapeutics Inc.
Thryv Therapeutics Inc. is a privately … Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine … Syndromes (LQTS), atrial fibrillation and heart failure, with potent and selective inhibitors …